Presented By: Melody Chang
Speaker Biography: Melody Chang is a Segment Marketing Manager for Vaccines and Synthetic Biology at GenScript. She has more than a decade of experience in the life-sciences industry, working as a drug registration specialist and later as a reagent product manager in charge of a variety of product lines. Currently Melody is responsible for the GenScript's vaccine and synthetic biology solutions.
Webinar: GenScript's Solutions for Advancing the Development of Neoantigen Vaccines with Live Q&A
Webinar Abstract: Neoantigen vaccines are a type of personalized cancer vaccine. While clinical trials have shown promising results, it is important to note that neoantigen vaccines are still in the early stages of development. Further research is needed to develop successful anti-cancer vaccines. For example, one of the challenges is identifying vaccine delivery systems that allow vaccines to be produced quickly and cost-effectively. In this webinar, we will review neoantigen vaccines and their current status. We will discuss the different vaccine formats, especially peptide and mRNA, and GenScript's solutions for advancing the development of neoantigen vaccines.
Labroots on Social:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Pinterest: [ Ссылка ]
SnapChat: labroots_inc
